Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus

被引：2

作者：

Al Awadhi, Sameer ^{[1
]}

Alboraie, Mohamed ^{[2
]}

Albaba, Emad Aldin ^{[3
]}

Almutairdi, Abdulelah ^{[4
]}

Alsaad, Monther ^{[5
]}

Azzam, Nahla ^{[6
]}

Barakat, Husam ^{[7
]}

D'Amico, Ferdinando ^{[8
,9
,10
]}

Danese, Silvio ^{[8
,9
]}

El Kady, Mohamed ^{[11
]}

Ghoneim, Hossam ^{[12
]}

Hamoudi, Waseem ^{[13
]}

Jazzar, Ahmad ^{[14
]}

Mosli, Mahmoud ^{[15
]}

Shehab, Hany ^{[16
]}

Sneineh, Awni Abu ^{[17
]}

机构：

[1] Rashid Hosp, Digest Dis Unit, Dubai 003206, U Arab Emirates

[2] Al Azhar Univ, Dept Internal Med, Cairo 11884, Egypt

[3] Almana Gen Hosp, Dept Med, Al Khobar 31952, Saudi Arabia

[4] King Faisal Specialist Hosp & Res Ctr, Dept Med, Riyadh 11564, Saudi Arabia

[5] Al Madar Med Ctr, POB 80789, Sharjah, U Arab Emirates

[6] King Saud Univ, Coll Med, Dept Med, Div Gastroenterol, Riyadh 11451, Saudi Arabia

[7] Yarmouk Univ, Dept Gastroenterol, Irbid 21163, Jordan

[8] IRCCS Osped San Raffaele, Gastroenterol & Endoscopy, I-20132 Milan, Italy

[9] Univ Vita Salute San Raffaele, I-20132 Milan, Italy

[10] Humanitas Univ, Dept Biomed Sci, I-20132 Milan, Italy

[11] Cairo Univ, Fac Med, Dept Med Pharmacol, Cairo 11559, Egypt

[12] Alexandria Univ, Med Res Inst, Immunol & Allergy Dept, Alexandria 5424041, Egypt

[13] Al Bashir Hosp, Internal Med Dept, Amman 11151, Jordan

[14] Sheikh Khalifa Med City, Gastroenterol Div, Abu Dhabi 51900, U Arab Emirates

[15] King Abdulaziz Univ Hosp, Dept Med, Jeddah 21589, Saudi Arabia

[16] Cairo Univ, Integrated Clin & Res Ctr Intestinal Disorders IC, Endem Med Dept, Gastroenterol Div, Cairo 3725121, Egypt

[17] Univ Jordan, Gastroenterol & Hepatol, Amman 11942, Jordan

来源：

JOURNAL OF CLINICAL MEDICINE | 2023年 / 12卷 / 21期

关键词：

5-ASA; mesalazine; budesonide MMX; ulcerative colitis; inflammatory bowel disease; RANDOMIZED CLINICAL-TRIAL; INFLAMMATORY-BOWEL-DISEASE; VS; 2.4; G/DAY; ORAL MESALAZINE; TOPICAL; 5-AMINOSALICYLATES; DOUBLE-BLIND; MAINTENANCE; REMISSION; EFFICACY; GUIDELINES;

D O I：

10.3390/jcm12216929

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The prevalence of ulcerative colitis (UC) in the Middle East is increasing, impacting the economic and healthcare burden. The management of patients with mild to moderate UC is still a challenge as several factors can affect optimal care, including drug choice, induction and maintenance dose, treatment optimization and de-escalation, therapy duration, monitoring, and safety profile. We conducted an expert consensus to standardize the management of patients with mild to moderate UC. Sixteen experts in inflammatory bowel diseases, through a well-established and accepted Delphi methodology, voted and approved eight statements in order to provide practical guidance to clinicians in the Middle East.

引用

页数：11

共 50 条

[1] Practical management of mild-to-moderate ulcerative colitis: an international expert consensus
D'Amico, Ferdinando
Magro, Fernando
Dignass, Axel
Al Awadhi, Sameer
Gutierrez Casbas, Ana
Queiroz, Natalia Sousa Freitas
Rydzewska, Grazyna
Duk Ye, Byong
Ran, Zhihua
Hart, Ailsa
Jairath, Vipul
Fiorino, Gionata
Peyrin-Biroulet, Laurent
Danese, Silvio
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 18 (08) : 421 - 430
[2] Management and treatment optimization of patients with mild to moderate ulcerative colitis
D'Amico, Ferdinando
Fasulo, Ernesto
Jairath, Vipul
Paridaens, Kristine
Peyrin-Biroulet, Laurent
Danese, Silvio
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2024, 20 (03) : 277 - 290
[3] Optimizing treatment of mild to moderate ulcerative colitis: CU-forum Delphi consensus
Cuffi, Miquel Sans
Arias, Federico Arguelles
Piudo, Ana Echarri
Vicens, Daniel Ginard
Casbas, Ana Gutierrez
Marin-Jimenez, Ignacio
GASTROENTEROLOGIA Y HEPATOLOGIA, 2023, 46 (10): : 784 - 794
[4] OLSALAZINE IN THE TREATMENT OF MILD TO MODERATE ULCERATIVE-COLITIS
ROBINSON, M
GITNICK, G
BALART, L
DAS, K
TURKIN, D
GASTROENTEROLOGY, 1988, 94 (05) : A381 - A381
[5] Spicing up the Treatment of Mild to Moderate Ulcerative Colitis
Bernstein, Charles N.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (08) : 1450 - 1452
[6] Ridogrel for the treatment of mild to moderate ulcerative colitis.
Skandalis, N
Rotenberg, A
Meuwissen, S
deGroot, GH
Ouwendijk, RJT
Tan, TG
GASTROENTEROLOGY, 1996, 110 (04) : A1016 - A1016
[7] International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
Caron, Benedicte
Jairath, Vipul
D'Amico, Ferdinando
Al Awadhi, Sameer
Dignass, Axel
Hart, Ailsa L.
Kobayashi, Taku
Kotze, Paulo Gustavo
Magro, Fernando
Siegmund, Britta
Paridaens, Kristine
Danese, Silvio
Peyrin-Biroulet, Laurent
MEDICINA-LITHUANIA, 2023, 59 (01):
[8] Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis
Agilli, Mehmet
Dogan, Tolga
Ergin, Giray
INFLAMMATORY BOWEL DISEASES, 2015, 21 (08) : E14 - E15
[9] Clinical Study on Saccharomyces Boulardii in the Treatment of Patients with Mild to Moderate Ulcerative Colitis
Tang, Hai-Ying
Wu, Hao
Mao, Jing-Wei
Zhu, Lei
Li, Na
Wang, Ying-De
11TH IEEE INTERNATIONAL CONFERENCE ON CONTROL AND AUTOMATION (ICCA), 2014, : 734 - 737
[10] Mild-to-moderate ulcerative colitis
Kruis, W.
Bohm, S.
Emerging Issues in Inflammatory Bowel Diseases, 2006, 151 : 169 - 173

← 1 2 3 4 5 →